Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,271.20
(
-0.70%
)
Dow Jones
47,916.57
(
0.00%
)
Brent Oil
99.20
(
-0.66%
)
Bitcoin
70,912.07
(
0.20%
)
News Focus
News Focus
Post# of 30387
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: bestvaluestocks post# 27578

Friday, 11/05/2010 5:51:36 PM

Friday, November 05, 2010 5:51:36 PM

Post# of 30387
Great Grandma, Opportunity needs to relax a bit.

First of all, there is nothing about RECAF that can be patented. The receptor is in public domain and can be used by anyone. Others are already using synthetic peptides and undoubtedly already have patents for cancer cell delivery.

It may be very difficult for Moro to get his patent approved.

http://www.nytimes.com/2010/08/24/health/24drug.html

How are the guys above getting their drug delivered to the cell via the synthetic peptide. Is it passing through via RECAF?

GoldSeeker™

I have never shorted nor intend to have any financial interest in BOCX. I am not connected with anyone who trades, shorts or has financial interests in BOCX. I only post facts and my opinions. I do not post on IHUB with different aliases.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today